ArticleCancer discovery2024

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.

Dian Kortleve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.